ephedrine hydrochloride
pharmacy retailing (nz) ltd t/a healthcare logistics - ephedrine hydrochloride 3 mg/ml - solution for injection - 30 mg/10ml - active: ephedrine hydrochloride 3 mg/ml excipient: citric acid sodium chloride sodium citrate water for injection - indicated for the treatment of hypotension secondary to spinal anaesthesia.
pseudodine c- triprolidine hydrochloride, pseudoephedrine hydrochloride and codeine phosphate syrup
wockhardt usa, inc. - triprolidine hydrochloride (unii: yan7r5l890) (triprolidine - unii:2l8t9s52qm), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f), codeine phosphate (unii: gsl05y1mn6) (codeine - unii:q830pw7520) - syrup - 1.25 mg in 5 ml - pseudodine™ c cough syrup is indicated for temporary relief of coughs and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold. pseudodine™ c cough syrup is contraindicated under the following conditions: this drug should not be used in newborn or premature infants. antihistamines should not be used to treat lower respiratory tract symptoms, including asthma. (1) codeine phosphate or other narcotics; (2) triprolidine hydrochloride or other antihistamines of similar chemical structure; or (3) sympathomimetic amines, including pseudoephedrine. sympathomimetic amines are contraindicated in patients with severe hypertension, severe coronary artery disease and in patients on monoamine oxidase (mao) inhibitor therapy (see precautions, drug interactions ). like other medications containing a narcotic, pseudodine™ c cough syrup is controlled by the drug enforcement administration. it is classified under schedule v. codeine can produce drug dependence of the morphine typ
fexofenadine hydrochloride and pseudoephedrine hydrochloride tablet, film coated, extended release
rebel distributors corp - fexofenadine hydrochloride (unii: 2s068b75zu) (fexofenadine - unii:e6582loh6v), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - fexofenadine hydrochloride 60 mg - fexofenadine hydrochloride and pseudoephedrine hydrochloride extended-release tablets are indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 12 years of age and older. symptoms treated effectively include sneezing, rhinorrhea, itchy nose/palate/ and/or throat, itchy/watery/red eyes, and nasal congestion. fexofenadine hydrochloride and pseudoephedrine hydrochloride extended-release tablets should be administered when both the antihistaminic properties of fexofenadine hydrochloride and the nasal decongestant properties of pseudoephedrine hydrochloride are desired (see clinical pharmacology). fexofenadine hydrochloride and pseudoephedrine hydrochloride extended-release tablets are contraindicated in patients with known hypersensitivity to any of its ingredients. due to its pseudoephedrine component, fexofenadine hydrochloride and pseudoephedrine hydrochloride extended-release tablets are contraindicated in patients with narrow-angle glaucoma or urinary retentio
ephedrine hydrochloride 3 mg/ml solution for injection in pre-filled syringe
laboratoire aguettant - ephedrine hydrochloride - solution for injection in pre-filled syringe - 3 milligram(s)/millilitre - ephedrine
ephedrine hydrochloride 30mg in 1ml solution for injection
ethypharm - ephedrine hydrochloride - solution for injection - 30 milligram(s)/millilitre - ephedrine
hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine hydrochloride- hydrocodone bitartrate, chlorpheniramine mal
paddock laboratories, llc - hydrocodone bitartrate (unii: no70w886kk) (hydrocodone - unii:6yks4y3wq7), chlorpheniramine maleate (unii: v1q0o9oj9z) (chlorpheniramine - unii:3u6io1965u), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - hydrocodone bitartrate 5 mg in 5 ml - hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine hydrochloride oral solution is indicated for the temporary relief of cough and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold in patients 18 years of age and older. important limitations of use hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine hydrochloride oral solution is contraindicated for: hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine hydrochloride oral solution is also contraindicated in patients with: risk summary hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine hydrochloride oral solution is not recommended for use in pregnant women, including during or immediately prior to labor. prolonged use of opioids during pregnancy may cause neonatal opioid withdrawal syndrome [see warnings and precautions (5.13), clinical considerations ]. there are no available data with hydrocodone bitartrate, chlorpheniramine maleate and pseudo
rugby cetirizine hydrochloride and pseudoephedrine hydrochloride- cetirizine hydrochloride, pseudoephedrine hydrochloride tablet
rugby laboratories - cetirizine hydrochloride (unii: 64o047ktoa) (cetirizine - unii:yo7261me24), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - antihistamine nasal decongestant
pseudoephedrine hydrochloride- pseudoephedrine hcl tablet, film coated
proficient rx lp - pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - nasal decongestant
cetirizine hydrochloride and pseudoephedrine hydrochloride- cetirizine hydrochloride, pseudoephedrine hydrochloride tablet, film
padagis israel pharmaceuticals ltd - cetirizine hydrochloride (unii: 64o047ktoa) (cetirizine - unii:yo7261me24), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - antihistamine nasal decongestant
pseudoephedrine hydrochloride- pseudoephedrine hcl tablet, film coated
padagis israel pharmaceuticals ltd - pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - nasal decongestant